Ex Parte ALLISON et al - Page 9




            Appeal No. 2002-2164                                                                              
            Application No. 09/067,599                                                                        

            dependent claims does not remedy the deficiency in the Section 102 rejection applied              
            against claim 36.                                                                                 
                   For the foregoing reasons we sustain the rejection of claim 17, but do not sustain         
            the rejection of claim 18, 37, or 38, under 35 U.S.C. § 103 as being unpatentable over            
            Dosiere and Jeng.                                                                                 


                                               CONCLUSION                                                     
                   The rejection of claims 15, 16, 19, 20, and 33 under 35 U.S.C. § 102 as being              
            anticipated by Dosiere is affirmed. The rejection of claim 36 under 35 U.S.C. § 102 as            
            being anticipated by Dosiere is reversed.                                                         
                   The rejection of claim 33 under 35 U.S.C. § 103 as being anticipated by Williams           
            is reversed.                                                                                      
                   The rejection of claim 17 under 35 U.S.C. § 103 as being unpatentable over                 
            Dosiere and Jeng is affirmed.  The rejection of claims 18, 37, and 38 under 35 U.S.C.             
            § 103 as being unpatentable over Dosiere and Jeng is reversed.                                    
                   The examiner’s decision in rejecting claims 15-20, 33, and 36-38 is thus affirmed-         
            in-part.                                                                                          







                                                     -9-                                                      





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007